États-Unis · Plateformes & données · Investing.com

Helus Pharma to present Phase 3 depression trial results Monday

Publié par Investing.com · États-Unis il y a 1 h

Helus Pharma to present Phase 3 depression trial results Monday — Investing.com

Lire l'article complet sur Investing.com Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.investing.com)

À lire aussi

293,141 Guidewire Software, Inc. $GWRE Shares Sold by William Blair Investment Management LLC

The Motley Fool

U.S. Bancorp Pays Out 40% of Its Profit as Dividends. Here's How Much Room It Has to Raise Them.

Nvidia defends employee in Taiwan AI chip smuggling case

‘We had the worst fight’: I want my husband to retire at 65, but I don’t want to lose his $280,000 salary. Is that unreasonable?

Goldman Sachs’ calm 2027 forecast comes with a catch

Elon Musk's SpaceX Pulls Off Historic First — Starship Returns To Texas Launchpad And Gets Caught By Mechazilla